Fertility Treatments and Multiple Births in the United States

Size: px
Start display at page:

Download "Fertility Treatments and Multiple Births in the United States"

Transcription

1 The new england journal of medicine original article Fertility Treatments and Multiple Births in the United States Aniket D. Kulkarni, M.B., B.S., M.P.H., Denise J. Jamieson, M.D., M.P.H., Howard W. Jones, Jr., M.D., Dmitry M. Kissin, M.D., M.P.H., Maria F. Gallo, Ph.D., Maurizio Macaluso, M.D., Dr.P.H., and Eli Y. Adashi, M.D. ABSTRACT From the Women s Health and Fertility Branch, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta (A.D.K., D.J.J., D.M.K., M.F.G.); the Johns Hopkins School of Medicine, Baltimore (H.W.J.); the Eastern Virginia Medical School, Norfolk (H.W.J.); the Division of Biostatistics and Epidemiology, Cincinnati Children s Hospital Medical Center, Cincinnati (M.M.); and the Warren Alpert Medical School, Brown University, Providence, RI (E.Y.A.). Address reprint requests to Dr. Kulkarni at the Women s Health and Fertility Branch, Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 477 Buford Hwy., NE, Mailstop F-74, Atlanta, GA 3341, or at eof@cdc.gov. N Engl J Med 213;369: DOI: 1.156/NEJMoa Copyright 213 Massachusetts Medical Society Background The advent of fertility treatments has led to an increase in the rate of multiple births in the United States. However, the trends in and magnitude of the contribution of fertility treatments to the increase are uncertain. Methods We derived the rates of multiple births after natural conception from data on distributions of all births from 1962 through 1966 (before fertility treatments were available). Publicly available data on births from 1971 through 211 were used to determine national multiple birth rates, and data on in vitro fertilization (IVF) from 1997 through 211 were used to estimate the annual proportion of multiple births that were attributable to IVF and to non-ivf fertility treatments, after adjustment for maternal age. Trends in multiple births were examined starting from 1998, the year when clinical practice guidelines for IVF were developed with an aim toward reducing the incidence of multiple births. Results We estimated that by 211, a total of 36% of twin births and 77% of triplet and higher-order births resulted from conception assisted by fertility treatments. The observed incidence of twin births increased by a factor of 1.9 from 1971 to 29. The incidence of triplet and higher-order births increased by a factor of 6.7 from 1971 to 1998 and decreased by 29% from 1998 to 211. This decrease coincided with a 7% reduction in the transfer of three or more embryos during IVF (P<.1) and a 33% decrease in the proportion of triplet and higher-order births attributable to IVF (P<.1). Conclusions Over the past four decades, the increased use of fertility treatments in the United States has been associated with a substantial rise in the rate of multiple births. The rate of triplet and higher-order births has declined over the past decade in the context of a reduction in the transfer of three or more embryos during IVF. (Funded by the Centers for Disease Control and Prevention.) 2218 n engl j med 369;23 nejm.org december 5, 213

2 fertility Treatments and Multiple Births In vitro fertilization (IVF) and non-ivf fertility treatments (i.e., ovulation induction and ovarian stimulation) constitute major risk factors for the genesis of multiple births (twin, triplet, and higher-order births). 1 IVF procedures, which are defined as procedures in which eggs and sperm are manipulated with the purpose of establishing a pregnancy, represent the overwhelming majority of procedures for assisted reproductive technology. Ovulation induction and ovarian stimulation, which are often included as part of the IVF process, are also coupled with timed intercourse or intrauterine insemination to establish a pregnancy independently of IVF. In ovulation induction, drugs are administered to induce ovulation in women who are otherwise anovulatory. 2 In contrast, ovarian stimulation is a process in which drugs are used to promote multifollicular ovarian development and ovulation in women who are subfertile. 2 Multiple births resulting from fertility treatments are associated with increased health risks for women and their offspring, 3-6 as well as substantial financial costs to families and society. 7,8 Limiting the number of embryos transferred during IVF cycles is important for reducing multiple births. 9,1 Although the practice of transferring three or more embryos in a single cycle has declined steadily, several factors may constrain efforts at further reduction. First, competition among fertility clinics may result in an intense focus on per-cycle pregnancy rates. 11 Second, financial exigencies encountered by patients may drive up the number of embryos transferred in the hope of maximizing per-cycle pregnancy rates. 12 Finally, patient acceptance of multiple births and the risks thereof may contribute to the transfer of more embryos. 13 Whereas the use of IVF is documented in a congressionally mandated national registry in the United States, the use of non-ivf fertility treatments is not and thus is not directly ascertainable. Nevertheless, non-ivf fertility treatments are associated with a substantial proportion of multiple births and have been shown to account for more multiple births than IVF. 17,18 In this study, we expanded on these earlier observations by conducting a longitudinal analysis to determine the trends in and magnitude of the contribution of fertility treatments to multiple births. Methods Estimation of the Rate of Multiple Births This study was approved by the institutional review board at the Centers for Disease Control and Prevention (CDC). We used publicly available birth data from the National Center for Health Statistics (NCHS) of the CDC to determine the annual national rates of multiple births over the course of the four decades (1971 through 211) during which fertility treatments have been available in the United States. 19 To correct for the effect of maternal age on multiple births, rates of twin births and of triplet and higher-order births, adjusted for maternal age, were calculated with the use of direct standardization, with the distribution of maternal age (<3, 3 to 34, 35 to 39, and 4 years) in 1971 used for the standard population. 2,21 The unit of analysis for a live birth was the live-born infant, not the delivery that resulted in a live-born infant. A live-born infant delivered from a multiplegestation pregnancy was included in the category of multiple birth. Rates of twin births and of triplet and higher-order births were calculated per 1 live births (i.e., per 1 live-born infants). Although NCHS birth data include all live births in the United States, we included only live births for which the mother resided in 1 of the 5 states or the District of Columbia. Estimation of Proportion of Multiple Births Resulting from Medically Assisted Conception Currently, the characterization of births as resulting from medically assisted conception versus natural conception is not included in data on vital statistics; hence, we had to estimate the relative contributions of births from these types of conception from the national incidence of multiple births. Medically assisted conceptions were defined as those that resulted from IVF or other fertility treatments, whereas natural conceptions were defined as those that were not assisted by fertility treatment. Since data on births resulting from IVF are available only from 1997 on, multiple births resulting from medically assisted versus natural conception were estimated for the period from 1997 through 211. Using a method similar to the method for estimating maternal age adjusted national rates of multiple births, we estimated the proportion of multiple births resulting from natural conception and the propor- n engl j med 369;23 nejm.org december 5,

3 The new england journal of medicine tion resulting from medically assisted conception using direct standardization, with the distribution of maternal age (<3, 3 to 34, 35 to 39, and 4 years) in 1997 used for the standard population. Direct standardization allowed us to account for the effect of maternal age in order to make the proportions comparable across years. Because the years 1962 through 1966 predated the availability of fertility treatments, we assumed that the distribution of the plurality of all births (singletons, twins, and triplets and higher-order multiples) during this period would approximate the distribution of the plurality of births from natural conceptions in the period from 1997 through 211. With this assumption, we estimated the annual occurrence of twin births and of triplet and higherorder births from natural conception. Next, we estimated the annual proportions of twin births and of triplet and higher-order births attributable to medically assisted conceptions by calculating the differences between the national numbers of multiple births and the estimated numbers of multiple births from natural conception. Estimation of Proportion of Multiple Births Resulting from IVF Using data from the National ART [Assisted Reproductive Technology] Surveillance System (NASS) of the CDC, we estimated the annual proportion of multiple births from medically assisted conceptions that involved IVF. We included in this category multiple births from all assisted reproductive technology procedures namely, IVF, gamete intrafallopian transfer, and zygote intrafallopian transfer with IVF accounting for an overwhelming majority of these procedures (>99% currently). The remaining births from medically assisted conceptions were classified as multiple births resulting from non-ivf fertility treatments. Clinics are federally mandated to report to the CDC information on their IVF procedures and the outcomes. 22 Currently, the NASS captures data on more than 95% of IVF procedures performed annually in the United States. IVF data have been available since Since there is no national registry for non-ivf fertility treatments, we estimated the proportion of multiple births from non-ivf fertility treatments by calculating the difference between the total number of medically assisted multiple births and the corresponding number of multiple births from IVF. NASS data were also used to describe the secular changes in the rates of live births resulting from IVF-assisted conception and in the number of embryos transferred during IVF, including the use of elective and nonelective single-embryo transfers during procedures in which fresh rather than frozen embryos were transferred. Singleembryo transfers during IVF were classified as elective if one embryo was transferred and at least one embryo was cryopreserved. The remaining single-embryo transfers, in which no embryos were cryopreserved during the procedure, were classified as nonelective single-embryo transfers. Guidelines for Reducing Multiple Births Resulting from IVF The Society for Assisted Reproductive Technology first developed practice guidelines aimed at reducing multiple births in The guidelines focused on limiting the number of embryos transferred during an IVF procedure. Revised guidelines have been published multiple times since Because we expected the 1998 guidelines to effect a change in the proportion of multiple births resulting from IVF in the years after 1998, we performed a test for trend for the overall period from 1998 through 211. We used linear regression, in which the outcome was the proportion of twin or triplet and higher-order births resulting from IVF and non-ivf treatments and the explanatory variable was the year. Similarly, we performed a test for trend for national multiple birth rates and the number of embryos transferred during IVF for the period from 1998 through 211, to evaluate the effects of the 1998 guidelines. Results Observed Rates of Multiple Births The observed national rates of twin births and of triplet and higher-order births from 1971 through 211 are shown in Figure 1. The observed rate of twin births (Fig. 1A) increased by a factor of 1.9 from 1971 to 29, the year in which the highest rate was observed, whereas the observed rate of triplet and higher-order births (Fig. 1C) increased by a factor of 6.7, with the highest rate seen in From 1998 to 211, the rate of triplet and higher-order births declined by 29%, from 1.94 to 1.37 per 1 live births (P<.1 for trend). The overall proportion of total national births that 222 n engl j med 369;23 nejm.org december 5, 213

4 fertility Treatments and Multiple Births A Observed and Maternal Age Adjusted Rates of Twin Births 35 Observed 3 National Twin Births (no. per 1 live births) Age-adjusted B Observed Maternal Age Pattern for Twin Births Maternal Age (% of national twin births) <3 Yr Yr Yr 4 Yr C Observed and Maternal Age Adjusted Rates of Triplet and Higher-Order Births National Triplet and Higher-Order Births (no. per 1 live births) Observed Age-adjusted D Observed Maternal Age Pattern for Triplet and Higher-Order Births Maternal Age (% of national triplet and higher-order births) 9 8 <3 Yr Yr Yr 1 4 Yr Figure 1. Rates of Multiple Births, Shown are observed national rates of twin births (Panel A) and triplet and higher-order births (Panel C), as well as the rates adjusted for maternal age, for the period from 1971 to 211. Also shown are observed maternal age patterns for twin births (Panel B) and triplet and higher-order births (Panel D) during the same period. were multiple births grew from 1.8% in 1971 to 3.5% in 211. Given the effect of maternal age on multiple births, we plotted the observed maternal age patterns for twin births (Fig. 1B) and triplet and higher-order births (Fig. 1D) from 1971 through 211. Over the course of this period, the proportion of twin births and of triplet and higher-order births among women younger than 3 years of age declined by 39% and 6%, respectively. In contrast, the proportion of all multiple births among women older than 3 years of age more than doubled, from 24% to 54% (a 125% increase). After adjustment for maternal age, the national rate of twin births (Fig. 1A) increased by a factor of 1.6 from 1971 to 29, the year in which the highest rate was observed, and the national rate of triplet and higher-order births (Fig. 1C) increased by a factor of 4.8 from 1971 to 1998, the year in which the highest rate was observed. Estimated Proportions of Multiple Births According to Method of Conception Figure 2 shows the estimated national proportions, adjusted for maternal age, of twin births and of triplet and higher-order births resulting from natural conception, medically assisted conception, IVF, and non-ivf fertility treatments from 1997 to 211. We estimated that the proportion of twin births resulting from medically assisted conceptions rose from 27% in 1998 to 36% in 211 n engl j med 369;23 nejm.org december 5,

5 The new england journal of medicine A Twin Births 9 Method of Conception (% of national twin births) B Triplet and Higher-Order Births 9 Method of Conception (% of national triplet and higher-order births) IVF Natural conception Natural conception Medically assisted conception Non-IVF treatments Medically assisted conception Non-IVF treatments Figure 2. Multiple Births, According to Method of Conception, Shown are the estimated national proportions, adjusted for maternal age, of twin births (Panel A) and triplet and higher-order births (Panel B) that resulted from natural conception, medically assisted conception, in vitro fertilization (IVF), and non-ivf fertility treatments during the period from 1997 through 211. (P<.1 for trend). In contrast, we estimated that the proportion of triplet and higher-order births from medically assisted conceptions declined from 84% in 1998 to 77% in 211 (P<.1 for trend). From 1998 to 211, the estimated proportion of twin births that were attributable to IVF increased from 1% to 17% (a 7% increase, P<.1 for trend), and the proportion of triplet and higher-order births attributable to IVF declined from 48% to 32% (a 33% decrease, P<.1 IVF for trend). The estimated proportion of twin births that were attributable to non-ivf fertility treatments increased from 16% in 1998 to 19% in 211 (P =.8 for trend), and the estimated proportion of triplet and higher-order births attributable to non-ivf fertility treatments increased from 36% in 1998 to 45% in 211 (P<.1 for trend). IVF Birth Cohort The trends from 1997 through 211 for singleton, twin, and triplet and higher-order birth rates within the IVF birth cohort are shown in Figure 3. The rate of triplet and higher-order births attributable to IVF decreased by 79% from 1998 to 211, to a rate of 3 births per 1 IVF-related births in 211. Concurrently, the IVF singleton birth rate increased by 29%, to a rate of 544 births per 1 IVF-related births in 211. These trends converge to mark 25 as the first year during which multiple births accounted for less than 5% of the IVF birth cohort. Nevertheless, in 211, IVF accounted for 2% of all multiple births nationally. Figure 4 shows the annual proportion of IVF procedures during the years 1997 through 211 in which one, two, or three or more embryos were transferred. From 1998 to 211, the proportion of procedures in which three or more embryos were transferred declined by 7%, from 79% to 24% (P<.1 for trend). In contrast, from 1998 to 211, the proportion of IVF procedures in which two embryos were transferred increased from 16% to 55% (P<.1 for trend), and the proportion in which a single embryo was transferred increased from 6% to 21% (P<.1 for trend). Stratification of the fresh-embryo transfers into elective single transfers (i.e., those in which one embryo was transferred and at least one embryo was cryopreserved) and nonelective single transfers (i.e., those in which no embryos were cryopreserved during the procedure) revealed that the proportion of elective singleembryo transfers crossed the 1% mark in 25, increased by about 1% annually thereafter, and reached a rate of 9% by 211 (Fig. 4B). Discussion The high incidence of multiple births in the United States is a consequence of advanced maternal age at delivery and fertility treatments. 23,24 This conclusion is supported by the calculated observed and maternal-age adjusted national rates of twin births and triplet and higher-order births 2222 n engl j med 369;23 nejm.org december 5, 213

6 fertility Treatments and Multiple Births and the estimated proportions of twin births and triplet and higher-order births from conception assisted by fertility treatments. We estimated that by 211, a total of 36% of twin births and 77% of triplet and higher-order births were attributable to medically assisted conceptions. Despite these trends, several indicators suggest that the incidence of multiple births may be stabilizing. The rate of triplet and higher-order births peaked in 1998 and has been declining since then. This decrease has coincided with a 7% reduction in the transfer of three or more embryos during IVF and a 33% decrease in the proportion of triplet and higher-order births attributable to IVF. During the period from 1997 through 211, the increased reliance on single-embryo and doubleembryo transfers during IVF succeeded in reducing the rate of triplet and higher-order births. The forces underlying the decline in the number of embryos transferred probably include professional societies, which have repeatedly revised practice guidelines to include recommendations for lowering the number of embryos transferred during IVF. 25 Consideration must also be given to the effects of insurance coverage for IVF services, 26 ongoing public reporting, 27 promotion of single-embryo transfers, 28 and technological advances. The feasibility of culturing embryos beyond the early cleavage stage to the highly implantable blastocyst stage has led to the growing acceptance of single-embryo transfers. 29 The trends for non-ivf fertility treatments were less favorable than those observed for IVF, presumably reflecting an increase in multiple births attributed to the non-ivf treatments of ovulation induction and ovarian stimulation. An earlier study by Reynolds and colleagues with the use of data from 1997 through 2 identified non-ivf fertility treatments as the leading contributor to medically assisted multiple births. 18 The methods in that study were similar to the ones in our study (but without direct standardization for adjustment for maternal age), and the investigators used 1971 rates to estimate the number of multiple births from natural conception. Our findings suggesting that ovulation induction and ovarian stimulation are important contributors to the multiple birth rate is consistent with findings from other studies ,3 For example, in a clinical trial by Guzick and colleagues involving women who underwent ovarian superovulation and intrauterine insemination, a large proportion of pregnancies resulted in No. of Births per 1 IVF-related Births multiple births, including quadruplets, triplets, and twins. 31 Major strengths of our study were the use of maternal age distributions predating fertility treatments to estimate the rate of multiple births from natural conceptions and the use of direct standardization to estimate the proportions of multiple births that were attributable to IVF and to non-ivf fertility treatments. Thus, we were able to account for the difference in maternal age distribution between the period before and the period after the use of fertility treatments and to carry out a valid comparison of proportions from 1997 through 211. Our study has a few important limitations. First, because of the unavailability of outcome data according to obesity status, race, and ethnic group, we are unable to adjust for changes in these factors over time. It has previously been shown that obese women have an increased likelihood of delivering dizygotic twins, whereas the likelihood is reduced for Hispanic women. 32,33 A family history of twins, prior pregnancies, maternal height, and improved perinatal care are other factors that may confound our estimates. Second, our analysis may have overestimated the contribution of non-ivf fertility treatments. Some multiple births attributed to this type of treatment could represent unreported IVF births originating in nonreporting fertility clinics. Since 1997, an estimated 6.1 to 11.8% of fertility clinics have chosen to forgo public reporting. 22 Alternatively, some multiple births attributed to Singleton Twin Triplet and higher-order Figure 3. National Rates of Singleton, Twin, and Triplet and Higher-Order Live Births Resulting from IVF, n engl j med 369;23 nejm.org december 5,

7 The new england journal of medicine A No. of Embryos Transferred (% of total embryo transfers) B Category of Single-Embryo Transfer (% of fresh embryo transfers) or more Nonelective single Double Single Elective single Figure 4. Embryo Transfer during IVF, Panel A shows data on the transfer of one, two, or three or more embryos as a percentage of the total number of embryo-transfer procedures during the period from 1997 through 211. Panel B shows data on elective and nonelective single-embryo transfers as a percentage of the total number of procedures involving fresh-embryo transfers during the same period. Singleembryo transfers during IVF were defined as elective when one embryo was transferred and at least one embryo was cryopreserved. Single-embryo transfers in which no embryos were cryopreserved during the procedure were classified as nonelective. non-ivf treatments could reflect IVF births that have been lost to follow-up. However, these relative shortcomings are unlikely to have materially affected our findings because nonreporting clinics are typically small, 34 and validation of the reporting of births by clinics has been shown to be accurate. 35 Because of the lack of national birth data to distinguish between natural conception and non-ivf fertility treatments, our related estimates might be underestimated or overestimated to some extent. Finally, the reliance of this study on birth data probably resulted in an underestimation of the true extent of gestational plurality because it did not take into account spontaneous fetal loss and procedures for reducing multifetal gestation Reducing the rate of multiple births will require sustained efforts. Multiple births resulting from IVF are largely preventable by limiting the number of embryos transferred. Increased acceptance of elective single-embryo transfers is likely to require a shift in clinical emphasis from a cross-sectional cycle-centered mindset (i.e., pregnancy rate per cycle) to a longitudinal patient-centered outlook (i.e., cumulative pregnancy rate per patient). 39 It is much more difficult to prevent multiple births resulting from ovulation induction and ovarian stimulation because of unpredictable follicular growth dynamics. 4 Monitoring notwithstanding, the number of oocytes destined to ovulate and fertilize cannot be reliably predicted. 2,41 However, adherence to prudent practice patterns, including the use of low-dose gonadotropins, could reduce the rate of multiple births while maintaining acceptable per-cycle pregnancy rates. 42 The Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation study (AMIGOS; ClinicalTrials.gov number, NCT144862), which is currently being conducted by the Reproductive Medicine Network, may provide a better understanding of how rates of multiple gestations might be reduced among women undergoing ovulation induction and ovarian stimulation. Consideration should also be given to expanding current public reporting to include ovulation induction and ovarian stimulation. Finally, valid and complete implementation of changes to birth certificates to capture births resulting from various fertility treatments could prove to be helpful. In conclusion, the rate of triplet and higherorder births has declined over the past decade in the context of a reduction in the transfer of three or more embryos during IVF. Increased awareness of multiple births resulting from non-ivf fertility treatments may lead to improved medical practice patterns and a decrease in the rate of multiple births. Supported by the Centers for Disease Control and Prevention. Dr. Adashi reports receiving fees for board membership from and holding stock in Alere. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org n engl j med 369;23 nejm.org december 5, 213

8 fertility Treatments and Multiple Births References 1. Assisted reproductive technology surveillance United States, 26. MMWR Surveill Summ 29;58: Practice Committee of the American Society for Reproductive Medicine. Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion. Fertil Steril 212;97: Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol 27; 19: MacKay AP, Berg CJ, King JC, Duran C, Chang J. Pregnancy-related mortality among women with multifetal pregnancies. Obstet Gynecol 26;17: Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 22;346: Sutcliffe AG, Derom C. Follow-up of twins: health, behaviour, speech, language outcomes and implications for parents. Early Hum Dev 26;82: Callahan TL, Hall JE, Ettner SL, Christiansen CL, Greene MF, Crowley WF Jr. The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N Engl J Med 1994;331: Collins J. Cost efficiency of reducing multiple births. Reprod Biomed Online 27;15:Suppl 3: Practice Committee opinion: guidelines on number of embryos transferred. Birmingham, AL: American Society for Assisted Reproductive Medicine, January Ferraretti AP, Goossens V, de Mouzon J, et al. Assisted reproductive technology in Europe, 28: results generated from European registers by ESHRE. Hum Reprod 212;27: Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology. Guidelines on number of embryos transferred. Fertil Steril 29;92: Jain T, Hornstein MD. Disparities in access to infertility services in a state with mandated insurance coverage. Fertil Steril 25;84: Ryan GL, Zhang SH, Dokras A, Syrop CH, Van Voorhis BJ. The desire of infertile patients for multiple births. Fertil Steril 24;81: Dickey RP. The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation to limit the number of embryos transferred. Fertil Steril 27;88: Contribution of assisted reproductive technology and ovulation-inducing drugs to triplet and higher-order multiple births United States, MMWR Morb Mortal Wkly Rep 2;49: Martin JA, Hamilton BE, Osterman MJK. Three decades of twin births in the United States, NCHS data brief no 8. Hyattsville, MD: National Center for Health Statistics Schieve LA, Devine O, Boyle CA, Petrini JR, Warner L. Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births. Am J Epidemiol 29;17: Reynolds MA, Schieve LA, Martin JA, Jeng G, Macaluso M. Trends in multiple births conceived using assisted reproductive technology, United States, Pediatrics 23;111: Centers for Disease Control and Prevention, National Center for Health Statistics. Datasets and related documentation for birth data ( nchs/nvss/birth_methods.htm). 2. Beemsterboer SN, Homburg R, Gorter NA, Schats R, Hompes PG, Lambalk CB. The paradox of declining fertility but increasing twinning rates with advancing maternal age. Hum Reprod 26;21: Bortolus R, Parazzini F, Chatenoud L, Benzi G, Bianchi MM, Marini A. The epidemiology of multiple births. Hum Reprod Update 1999;5: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health. Assisted reproductive technology (ART): annual ART success rate reports ( art/artreports.htm). 23. Templeton A. Joseph Price oration: the multiple gestation epidemic the role of the assisted reproductive technologies. Am J Obstet Gynecol 24;19: Adashi EY, Barri PN, Berkowitz R, et al. Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic. Reprod Biomed Online 23;7: Practice Committee of Society for Assisted Reproductive Technology, Practice Committee of American Society for Reproductive Medicine. Elective single-embryo transfer. Fertil Steril 212;97: Jain T, Harlow BL, Hornstein MD. Insurance coverage and outcomes of in vitro fertilization. N Engl J Med 22;347: Adashi EY, Wyden R. Public reporting of clinical outcomes of assisted reproductive technology programs: implications for other medical and surgical procedures. JAMA 211;36: Kresowik JD, Stegmann BJ, Sparks AE, Ryan GL, van Voorhis BJ. Five-years of a mandatory single-embryo transfer (mset) policy dramatically reduces twinning rate without lowering pregnancy rates. Fertil Steril 211;96: Blake DA, Farquhar CM, Johnson N, Proctor M. Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev 27;4: CD Cook JL, Geran L, Rotermann M. Multiple births associated with assisted human reproduction in Canada. J Obstet Gynaecol Can 211;33: Guzick DS, Carson SA, Coutifaris C, et al. Efficacy of superovulation and intrauterine insemination in the treatment of infertility. N Engl J Med 1999;34: Reddy UM, Branum AM, Klebanoff MA. Relationship of maternal body mass index and height to twinning. Obstet Gynecol 25;15: Multiple pregnancy and birth: twins, triplets, and higher order multiples: a guide for patients. Rev. ed. Birmingham AL: American Society for Reproductive Medicine, Kissin DM, Jamieson DJ, Barfield WD. Assisted reproductive technology program reporting. JAMA 211;36: Assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta: Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology, 29 ( ART_29_Full.pdf). 36. Barton SE, Missmer SA, Hornstein MD. Twin pregnancies with a vanished embryo: a higher risk multiple gestation group? Hum Reprod 211;26: Wimalasundera RC. Selective reduction and termination of multiple pregnancies. Semin Fetal Neonatal Med 21;15: Stone J, Eddleman K, Lynch L, Berkowitz RL. A single center experience with 1 consecutive cases of multifetal pregnancy reduction. Am J Obstet Gynecol 22;187: Luke B, Brown MB, Wantman E, et al. Cumulative birth rates with linked assisted reproductive technology cycles. N Engl J Med 212;366: Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update 212;18: Dickey RP. Strategies to reduce multiple pregnancies due to ovulation stimulation. Fertil Steril 29;91: Cantineau AE, Cohlen BJ, Heineman MJ. Ovarian stimulation protocols (antioestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility. Cochrane Database Syst Rev 27;2:CD5356. Copyright 213 Massachusetts Medical Society. n engl j med 369;23 nejm.org december 5,

International Federation of Fertility Societies. Global Standards of Infertility Care

International Federation of Fertility Societies. Global Standards of Infertility Care International Federation of Fertility Societies Global Standards of Infertility Care Standard 8 Reducing the incidence of multiple pregnancy following treatment for infertility Name Version number Author

More information

INSURANCE COVERAGE AND IN VITRO FERTILIZATION. Special Article INSURANCE COVERAGE AND OUTCOMES OF IN VITRO FERTILIZATION

INSURANCE COVERAGE AND IN VITRO FERTILIZATION. Special Article INSURANCE COVERAGE AND OUTCOMES OF IN VITRO FERTILIZATION INSURANCE AND IN VITRO FERTILIZATION Special Article INSURANCE AND OUTCOMES OF IN VITRO FERTILIZATION TARUN JAIN, M.D., BERNARD L. HARLOW, PH.D., AND MARK D. HORNSTEIN, M.D. ABSTRACT Background Although

More information

CONTROVERSY: INSURANCE COVERAGE

CONTROVERSY: INSURANCE COVERAGE CONTROVERSY: INSURANCE COVERAGE FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A.

More information

CONTROVERSY: MULTIPLE BIRTHS: WHAT DO PATIENTS WANT?

CONTROVERSY: MULTIPLE BIRTHS: WHAT DO PATIENTS WANT? CONTROVERSY: MULTIPLE BIRTHS: WHAT DO PATIENTS WANT? FERTILITY AND STERILITY VOL. 81, NO. 3, MARCH 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free

More information

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health. Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive

More information

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE

Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE Human Reproduction, Vol.1, No.1 pp. 1 21, 2009 doi:10.1093/humrep/dep035 Hum. Reprod. Advance Access published February 18, 2009 ORIGINAL ARTICLE ESHRE Assisted reproductive technology and intrauterine

More information

Why Insurance Coverage Fails To Close The Access Gap To Artificial Reproductive Technology. Andrew Fisher, BSE, MS4.

Why Insurance Coverage Fails To Close The Access Gap To Artificial Reproductive Technology. Andrew Fisher, BSE, MS4. Why Insurance Coverage Fails To Close The Access Gap To Artificial Reproductive Technology Andrew Fisher, BSE, MS4 February 10, 2014 Submitted here for consideration for the Perelman School of Medicine

More information

SINCE THE GOAL OF IN VITRO FERtilization

SINCE THE GOAL OF IN VITRO FERtilization ORIGINAL CONTRIBUTION Live-Birth Rates and Multiple-Birth Risk Using In Vitro Fertilization Laura A. Schieve, PhD Herbert B. Peterson, MD Susan F. Meikle, MD Gary Jeng, PhD Isabella Danel, MD Nancy M.

More information

Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience,

Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, FERTILITY AND STERILITY VOL. 78, NO. 5, NOVEMBER 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Clinical outcomes

More information

Health technology Immediate in vitro fertilisation (IVF) was compared with gonadotropins followed by IVF as treatment for primary infertility.

Health technology Immediate in vitro fertilisation (IVF) was compared with gonadotropins followed by IVF as treatment for primary infertility. In vitro fertilization (IVF) versus gonadotropins followed by IVF as treatment for primary infertility: a cost-based decision analysis Kansal-Kalra S, Milad M P, Grobman W A Record Status This is a critical

More information

Births following fertility treatment in the GUI infant cohort. Aisling Murray Growing Up in Ireland, ESRI

Births following fertility treatment in the GUI infant cohort.  Aisling Murray Growing Up in Ireland, ESRI Births following fertility treatment in the GUI infant cohort www.growingup.ie Aisling Murray Growing Up in Ireland, ESRI About GUI Two cohorts: birth (9 months) and middle childhood (9 years) Current

More information

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine

Society for Assisted Reproductive Technology and American Society for Reproductive Medicine FERTILITY AND STERILITY VOL. 74, NO. 4, OCTOBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. ASRM/SART REGISTRY

More information

Disclosures. Win Fertility UpToDate

Disclosures. Win Fertility UpToDate Disclosures Win Fertility UpToDate Excess preterm birth Low birth weight Small for gestational age infants Neonatal death But prior studies limited by: Lack of statistical power Inaccurate vital records

More information

INFERTILITY SERVICES

INFERTILITY SERVICES INFERTILITY SERVICES Protocol: OBG036 Effective Date: August 1, 2018 Table of Contents Page COMMERCIAL COVERAGE RATIONALE... 1 DEFINITIONS... 4 MEDICARE AND MEDICAID COVERAGE RATIONALE... 5 REFERENCES...

More information

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Aila Tiitinen Professor, reproductive medicine Head of IVF unit Helsinki University The outline

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 1998, by the Massachusetts Medical Society VOLUME 9 A UGUST 7, 1998 NUMBER 9 REDUCING THE RISK OF MULTIPLE BIRTHS BY TRANSFER OF TWO EMBRYOS AFTER IN VITRO

More information

The evidence for insemination versus intercourse or IVF

The evidence for insemination versus intercourse or IVF To inseminate or not: that s the question! The evidence for insemination versus intercourse or IVF B.Cohlen, Genk 2009 There are believers and non-believers Ovarian stimulation protocols (anti-oestrogens,

More information

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction Trends in Egg Donation Vitaly A. Kushnir MD Center for Human Reproduction Disclosures No relevant financial relationships to disclose CHR views the commercial trade in human oocytes with considerable ethical

More information

Artigo original/original Article

Artigo original/original Article Artigo original/original Article Análise do registo português de procriação medicamente assistida: 1997-2005 A long-term analysis of the Portuguese assisted reproductive technologies data registry 1997-2005

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 2, by the Massachusetts Medical Society VOLUME 4 J ULY 6, 2 NUMBER 1 REDUCING THE RISK OF HIGH-ORDER MULTIPLE PREGNANCY AFTER OVARIAN STIMULATION WITH GONADOTROPINS

More information

Infertility Service Use among Fertility-Impaired Women in the United States:

Infertility Service Use among Fertility-Impaired Women in the United States: Infertility Service Use among Fertility-Impaired Women in the United States: 1995-2010 Anjani Chandra, Ph.D., CDC/National Center for Health Statistics Elizabeth Hervey Stephen, Ph.D., Georgetown University

More information

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management Dr Guy Gudex Director Repromed 17:00-17:30 Recent Advances in Fertility Management Recent Advances in Fertility Management Practice Nurses Programme NZMA GP CME June 2018 Dr Guy Gudex ART in NZ -2014 ACART

More information

Does a woman s educational attainment influence in vitro fertilization outcomes?

Does a woman s educational attainment influence in vitro fertilization outcomes? Does a woman s educational attainment influence in vitro fertilization outcomes? The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.

More information

Cumulative Birth Rates with Linked Assisted Reproductive Technology Cycles

Cumulative Birth Rates with Linked Assisted Reproductive Technology Cycles original article Cumulative Birth Rates with Linked Assisted Reproductive Technology Cycles Barbara Luke, Sc.D., M.P.H., Morton B. Brown, Ph.D., Ethan Wantman, M.B.A., Avi Lederman, B.A., William Gibbons,

More information

Progress we can be proud of: U.S. trends in assisted reproduction over the first 20 years

Progress we can be proud of: U.S. trends in assisted reproduction over the first 20 years FERTILITY AND STERILITY VOL. 78, NO. 5, NOVEMBER 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Progress we can be

More information

FACTORS ASSOCIATED WITH DIZYGOTIC TWINNING AFTER IVF TREATMENT WITH DOUBLE EMBRYO TRANSFER

FACTORS ASSOCIATED WITH DIZYGOTIC TWINNING AFTER IVF TREATMENT WITH DOUBLE EMBRYO TRANSFER FACTORS ASSOCIATED WITH DIZYGOTIC TWINNING AFTER IVF TREATMENT WITH DOUBLE EMBRYO TRANSFER HUM REPROD. 2012 OCT;27(10):2966-70. E. GROENEVELD, M.J. LAMBERS, M.E.F. STAKELBEEK, T.M. MOOIJ, A.W. VAN DEN

More information

Infertility, infertility treatment and twinning: the Danish National Birth Cohort

Infertility, infertility treatment and twinning: the Danish National Birth Cohort Human Reproduction pp. 1 5, 2007 Hum. Reprod. Advance Access published January 4, 2007 doi:10.1093/humrep/del495 Infertility, infertility treatment and twinning: the Danish National Birth Cohort Jin Liang

More information

Assisted Reproductive Technologies

Assisted Reproductive Technologies Assisted Reproductive Technologies ADDENDUM TO THE STEP REPORT August, 26 Submitted to: The Alberta Health Technologies Decision Process Research & Innovation Branch Strategic Planning & Policy Development

More information

Cumulative Live-Birth Rates after In Vitro Fertilization

Cumulative Live-Birth Rates after In Vitro Fertilization The new england journal of medicine original article Cumulative Live-Birth Rates after In Vitro Fertilization Beth A. Malizia, M.D., Michele R. Hacker, Sc.D., M.S.P.H., and Alan S. Penzias, M.D. ABSTRACT

More information

IVF Health Risk 503,000 Hit in Google in 0.2 seconds

IVF Health Risk 503,000 Hit in Google in 0.2 seconds Assisted Reproductive Technologies and Perinatal Morbidity: Interrogating the Association Kurt Barnhart, M.D., MSCE. William Shippen Jr Professor of Obstetrics and Gynecology and Epidemiology Perelman

More information

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019 JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019 Page 1 Table of Contents Executive Summary... 3 About this Guidance... 4 Glossary:... 5 ART

More information

Number of oocytes and live births in IVF

Number of oocytes and live births in IVF Number of oocytes and live births in IVF Dr Sesh K Sunkara MD, MRCOG Royal Marsden Hospital, London Kings Healthcare Partners (Guy s & St Thomas NHS Foundation Trust), London, UK Background IVF results

More information

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in

More information

Embryo Selection after IVF

Embryo Selection after IVF Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus

More information

Partner Name: Patient Signature Partner Signature (If applicable) Date (COS/IUI) Witness Name Witness Signature Date

Partner Name: Patient Signature Partner Signature (If applicable) Date (COS/IUI) Witness Name Witness Signature Date 1. Please place your initials below to indicate which components of controlled ovarian Stimulation (COS) and intrauterine insemination (IUI) treatment you agree to undertake in your upcoming treatment

More information

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their

More information

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.

Universal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D. Universal Embryo Cryopreservation: Frozen versus Fresh Transfer Zaher Merhi, M.D. Disclosure: None Fewer complications with IVF 1.5% children in US are born through ART 1.1 million children since 2006

More information

POSEIDON s stratification of Low prognosis patients in ART and its new proposed marker of successful outcome: The WHY, the WHAT, and the HOW

POSEIDON s stratification of Low prognosis patients in ART and its new proposed marker of successful outcome: The WHY, the WHAT, and the HOW POSEIDON s stratification of Low prognosis patients in ART and its new proposed marker of successful outcome: The WHY, the WHAT, and the HOW Sandro C. Esteves, MD., PhD. I. The WHY The management of patients

More information

European IVF Monitoring (EIM) Year: 2013

European IVF Monitoring (EIM) Year: 2013 European IVF Monitoring (EIM) Year: 2013 Name of the country Poland Name and full address of the contact person. Anna Janicka, PhD Polish Society of Reproductive Medicine and Embryology Fertility and Sterility

More information

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility

More information

Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018)

Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018) Islington CCG Fertility Policy First approved: 29 January 2015 Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018) Introduction Islington CCG

More information

IN VITRO FERTILIZATION

IN VITRO FERTILIZATION IN VITRO FERTILIZATION FERTILITY AND STERILITY VOL. 81, NO. 6, JUNE 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Use of

More information

Of Competitive Pressures and Care Quality: Infertility Treatment Case

Of Competitive Pressures and Care Quality: Infertility Treatment Case Of Competitive Pressures and Care Quality: Infertility Treatment Case Helen Schneider Department of Economics, University of Texas at Austin Importance of the Study About 11 percent of American women 15

More information

Bleeding and spontaneous abortion after therapy for infertility

Bleeding and spontaneous abortion after therapy for infertility FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Bleeding and spontaneous

More information

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve

More information

Keywords: annual reports, international literature, intrauterine insemination, multiple pregnancy, ongoing pregnancy, The Netherlands

Keywords: annual reports, international literature, intrauterine insemination, multiple pregnancy, ongoing pregnancy, The Netherlands RBMOnline - Vol 14. No 1. 2007 110-116 Reproductive BioMedicine Online; www.rbmonline.com/article/2440 on web 23 November 2006 The aim of this retrospective study was to assess the results of intrauterine

More information

United States Senate Committee on Health, Education, Labor, and Pensions

United States Senate Committee on Health, Education, Labor, and Pensions Memorandum To: United States Senate Committee on Health, Education, Labor, and Pensions Tom Harkin, Chairman Mike Enzi, Ranking Member From: Dave Cooke. Date: 02/18/2011 Re: Fertility Clinic Success Rate

More information

CONSENT TO CRYOPRESERVATION AND STORAGE OF HUMAN EMBRYOS

CONSENT TO CRYOPRESERVATION AND STORAGE OF HUMAN EMBRYOS 1. Name(s) of Party/Parties A. Party/parties requesting freezing of embryos a. Couple We, and of County, City of in the state of are (married or domestic partners) and are over the age of twenty-one years.

More information

Incomplete working draft, please do not quote without authors permission

Incomplete working draft, please do not quote without authors permission Will fertility of Danish women remain stable due to assisted reproduction? Assessing the role of assisted reproduction in sustaining cohort fertility rates Incomplete working draft, please do not quote

More information

Fertility Policy. December Introduction

Fertility Policy. December Introduction Fertility Policy December 2015 Introduction Camden Clinical Commissioning Group (CCG) is responsible for commissioning a range of health services including hospital, mental health and community services

More information

CLINICAL ASSISTED REPRODUCTION

CLINICAL ASSISTED REPRODUCTION CLINICAL ASSISTED REPRODUCTION IVF Births and Pregnancies: An Exploration of Two Methods of Assessment Using Life-Table Analysis R. DEONANDAN, 1,4 M. K. CAMPBELL, 1 T. OSTBYE, 2 I. TUMMON, 3 and J. ROBERTSON

More information

Patient selection criteria for blastocyst culture in IVF/ICSI treatment

Patient selection criteria for blastocyst culture in IVF/ICSI treatment J Assist Reprod Genet (2010) 27:555 560 DOI 10.1007/s10815-010-9457-9 ASSISTED REPRODUCTION Patient selection criteria for blastocyst culture in IVF/ICSI treatment M. Y. Thum & V. Wells & H. Abdalla Received:

More information

The cost-effectiveness of treatment for varicocele related infertility Penson D F, Paltiel D, Krumholz H M, Palter S

The cost-effectiveness of treatment for varicocele related infertility Penson D F, Paltiel D, Krumholz H M, Palter S The cost-effectiveness of treatment for varicocele related infertility Penson D F, Paltiel D, Krumholz H M, Palter S Record Status This is a critical abstract of an economic evaluation that meets the criteria

More information

Introduction. Laura A. Schieve 1 Christine Fountain. Dmitry M. Kissin 3 Denise J. Jamieson

Introduction. Laura A. Schieve 1 Christine Fountain. Dmitry M. Kissin 3 Denise J. Jamieson J Autism Dev Disord (2015) 45:2991 3003 DOI 10.1007/s10803-015-2462-1 ORIGINAL PAPER Does Autism Diagnosis Age or Symptom Severity Differ Among Children According to Whether Assisted Reproductive Technology

More information

Approved January Waltham Forest CCG Fertility policy

Approved January Waltham Forest CCG Fertility policy Approved January 2015 Waltham Forest CCG Fertility policy Contents 1 Introduction 1 2 Individual Funding Requests 1 2.1 Eligibility criteria 1 2.2 Number of cycles funded 2 2.3 Treatment Pathway 3 Page

More information

Single Embryo Transfer

Single Embryo Transfer Single Embryo Transfer Rachel Cutting Principal Embryologist Chair Association of Clinical Embryologists Summary Background to change in UK policy National data Strategies Embryo selection Practical requirements

More information

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception

More information

Dr Devashana Gupta. Dr Karen Buckingham. Obstetrician and Gynaecologist Repromed. Repromed Auckland

Dr Devashana Gupta. Dr Karen Buckingham. Obstetrician and Gynaecologist Repromed. Repromed Auckland Dr Karen Buckingham Obstetrician and Gynaecologist Repromed Dr Devashana Gupta Repromed Auckland 8:30-9:25 WS #93: Optimising Fertility - Periconception Management 9:35-10:30 WS #105: Optimising Fertility

More information

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO

More information

Improving Influenza Vaccination Rates in Pregnant Women

Improving Influenza Vaccination Rates in Pregnant Women Improving Influenza Vaccination Rates in Pregnant Women Melissa J. Sherman, M.D., Christina A. Raker, Sc.D., and Maureen G. Phipps, M.D., M.P.H. The Journal of Reproductive Medicine ORIGINAL ARTICLES OBJECTIVE:

More information

2018 INFERTILITY TRENDS NATIONAL SURVEY

2018 INFERTILITY TRENDS NATIONAL SURVEY REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY 2018 INFERTILITY TRENDS NATIONAL SURVEY WWW.RMANJ.COM 973-656-2089 REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY 2018 INFERTILITY TRENDS NATIONAL SURVEY

More information

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology Minimising IVF related mortality and morbidity Scott Nelson Muirhead Professor in Obstetrics & Gynaecology We rarely say no - so what I will cover today VTE as an example of a modifiable IVF complication

More information

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation

More information

Infertility services reported by men in the United States: national survey data

Infertility services reported by men in the United States: national survey data MALE FACTOR Infertility services reported by men in the United States: national survey data John E. Anderson, Ph.D., Sherry L. Farr, Ph.D., M.S.P.H., Denise J. Jamieson, M.D., M.P.H., Lee Warner, Ph.D.,

More information

DRAFT: PLEASE DO NOT CITE OR QUOTE WITHOUT PERMISSION OF AUTHORS

DRAFT: PLEASE DO NOT CITE OR QUOTE WITHOUT PERMISSION OF AUTHORS The Supply of and Demand for Assisted Reproductive Technologies in the United States: Clinic and Population Based Data, 1995-2010 *Elizabeth Hervey Stephen, Ph.D., Georgetown University Anjani Chandra,

More information

Subfertility & prognostic factors & intrauterine insemination

Subfertility & prognostic factors & intrauterine insemination Subfertility & prognostic factors & intrauterine insemination N.Cem FIÇICIOĞLU, M.D., Ph.D. Professor and Director Department of Gynecology & Obstetrics and IVF Center Yeditepe University, School of Medicine

More information

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr. Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art

More information

Follicular diameters in conception cycles with and without multiple pregnancy after stimulated ovulation induction

Follicular diameters in conception cycles with and without multiple pregnancy after stimulated ovulation induction Human Reproduction Page 1 of 5 Hum. Reprod. Advance Access published December 17, 2004 doi:10.1093/humrep/deh677 Follicular diameters in conception cycles with and without multiple pregnancy after stimulated

More information

a Department of Obstetrics, Gynecology and Reproductive Biology, Brigham & Women s Hospital, Harvard Medical School,

a Department of Obstetrics, Gynecology and Reproductive Biology, Brigham & Women s Hospital, Harvard Medical School, National collection of embryo morphology data into Society for Assisted Reproductive Technology Clinic Outcomes Reporting System: associations among day 3 cell number, fragmentation and blastomere asymmetry,

More information

Abstract. Introduction. Materials and methods. Patients and methods

Abstract. Introduction. Materials and methods. Patients and methods RBMOnline - Vol 8. No 3. 344-348 Reproductive BioMedicine Online; www.rbmonline.com/article/1178 on web 20 January 2004 Article Cumulative live birth rates after transfer of cryopreserved ICSI embryos

More information

Infertility treatment

Infertility treatment In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation

More information

*Correspondence address.

*Correspondence address. Human Reproduction, Vol.31, No.1 pp. 93 99, 2016 Advanced Access publication on November 3, 2015 doi:10.1093/humrep/dev270 ORIGINAL ARTICLE Infertility How do cumulative live birth rates and cumulative

More information

Articles Follow-up of children born after assisted reproductive technologies

Articles Follow-up of children born after assisted reproductive technologies RBMOnline - Vol 5. No 3. 317 322 Reproductive BioMedicine Online; www.rbmonline.com/article/669 on web 9 August 2002 Articles Follow-up of children born after assisted reproductive technologies Dr Michael

More information

Cost-effectiveness of intrauterine insemination with or without mild ovarian hyperstimulation. B.W. Mol

Cost-effectiveness of intrauterine insemination with or without mild ovarian hyperstimulation. B.W. Mol Cost-effectiveness of intrauterine insemination with or without mild ovarian hyperstimulation ESHRE Genk, Belgium, 15 December B.W. Mol Introduction Definitions Principles of economic analysis Effectiveness

More information

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017 MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.018.MH Infertility- Treatment This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar

More information

WHAT IS A PATIENT CARE ADVOCATE?

WHAT IS A PATIENT CARE ADVOCATE? WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Sandin S, Nygren K-G, Iliadou A, Hultman C, Reichenberg. Autism and Mental Retardation Among Offspring Born After In Vitro Fertilization. JAMA. doi:10.1001/jama.2013.7222.

More information

Pregnancy Outcome following Active Management of Endometriosis after Laparoscopy in Infertile Women A Prospective Cohort Study

Pregnancy Outcome following Active Management of Endometriosis after Laparoscopy in Infertile Women A Prospective Cohort Study ORIGINAL RESEARCH KERALA MEDICAL JOURNAL Pregnancy Outcome following Active Management of Endometriosis after Laparoscopy in Infertile Women A Prospective Cohort Study Anupama R KJK Hospital, Nalanchira,

More information

Recent Developments in Infertility Treatment

Recent Developments in Infertility Treatment Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other

More information

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 1 Standard Operating Procedure St Helens CCG NHS Funded Treatment for Sub Fertility Policy Version 1 Implementation Date May 2015 Review

More information

European IVF Monitoring (EIM) Year: 2012

European IVF Monitoring (EIM) Year: 2012 European IVF Monitoring (EIM) Year: 2012 Name of the country Poland Name and full address of the contact person. Professor Rafal Kurzawa, MD PhD Wojska Polskiego 103 Street 70-483 Szczecin Poland Telephone

More information

FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Société Suisse de Médecine de la Reproduction

FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Société Suisse de Médecine de la Reproduction SGRM / SSMR Schweizerische Gesellschaft für Reproduktionsmedizin FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Annual report 2013 Cycles 2012 Version 15.06.2014 Date of analysis 02.12.2013

More information

Reproductive Technologies and the Risk of Birth Defects

Reproductive Technologies and the Risk of Birth Defects original article Reproductive Technologies and the Risk of Birth Defects Michael J. Davies, M.P.H., Ph.D., Vivienne M. Moore, M.P.H., Ph.D., Kristyn J. Willson, B.Sc., Phillipa Van Essen, M.P.H., Kevin

More information

Infertility Treatment, ART and IUI Procedures and Delivery. Outcomes: How Important is Selection? 1

Infertility Treatment, ART and IUI Procedures and Delivery. Outcomes: How Important is Selection? 1 Infertility Treatment, ART and IUI Procedures and Delivery Outcomes: How Important is Selection? 1 Pooja G. Mookim 2, Randall P. Ellis 3, Ariella Kahn-Lang 4 May 1, 2008 Abstract: High infertility levels

More information

The cost of infertility diagnosis and treatment in Canada in 1995

The cost of infertility diagnosis and treatment in Canada in 1995 Human Reproduction vol.12 no.5 pp.951 958, 1997 The cost of infertility diagnosis and treatment in Canada in 1995 J.A.Collins 1,2,4, D.Feeny 3,2 and J.Gunby 1 treatment. This information is needed to provide

More information

Bradley J. Van Voorhis, MD

Bradley J. Van Voorhis, MD Bradley J. Van Voorhis, MD Articles: Eichholz AC,, Sorosky JI, Smith BJ, Sood AK. Operative note dictation: should it be taught routinely in residency programs? Obstet Gynecol. 2004 Feb;103(2):342-6 Ryan

More information

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO TREATMENT 3 4. DEFINITION

More information

Subject: Infertility Policy Effective Date: 01/07 Revision Date: 01/2018

Subject: Infertility Policy Effective Date: 01/07 Revision Date: 01/2018 Subject: Infertility Policy Effective Date: 01/07 Revision Date: 01/2018 DESCRIPTION Infertility is the condition of an individual who has been unable to conceive or produce conception during a period

More information

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life?

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? Vitaly A. Kushnir MD Center for Human Reproduction New York City Milestones

More information

Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017.

Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017. Fertility Policy 10 July 2017 Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017. Introduction BHR CCGs are responsible

More information

WHAT YOU DIDN T KNOW, BUT NEED TO

WHAT YOU DIDN T KNOW, BUT NEED TO WHAT YOU DIDN T KNOW, BUT NEED TO In 2016, 7 million people will try to conceive through natural pregnancy, but only 5 million will be successful 20% of women are born with low ovarian reserve 200,000

More information

Two commissioning alternatives are presented for consideration:

Two commissioning alternatives are presented for consideration: Item Number: 8 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING Meeting Date: 4 April 2013 Report Sponsor: Mark Hayes Chief Clinical Officer Report Author: North Yorkshire and Humber

More information

Does PCOS Compromise the oocyte and embryo quality or the endometrium?

Does PCOS Compromise the oocyte and embryo quality or the endometrium? Does PCOS Compromise the oocyte and embryo quality or the endometrium? Richard S. Legro, M.D., Penn State College of Medicine, Dept of Ob/Gyn, Hershey, PA, USA Disclosures Consultant: Bayer, Ogeda (Euroscreen),

More information

Clinical Policy Committee

Clinical Policy Committee Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments

More information

Risk of Spontaneous Abortion in Women with Childhood Exposure to Parental Cigarette Smoke

Risk of Spontaneous Abortion in Women with Childhood Exposure to Parental Cigarette Smoke American Journal of Epidemiology ª The Author 2007. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

More information

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes? Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes? Andrea Weghofer Foundation for Reproductive Medicine 2017 New York, November 16-19 Conflict of interest No relevant financial

More information

2017 United HealthCare Services, Inc.

2017 United HealthCare Services, Inc. UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017

More information

to find a more reliable scoring system to associate embryo morphology and pregnancy outcome.

to find a more reliable scoring system to associate embryo morphology and pregnancy outcome. Embryo quality is more important for younger women whereas age is more important for older women with regard to in vitro fertilization outcome and multiple pregnancy Tsung-Hsien Lee, M.D., M.Sc., a,b,c

More information

Treating Infertility

Treating Infertility Treating Infertility WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 About 10% of couples in the United States are infertile. Infertility is a condition in which a woman has not been able

More information